Clinical Trial Update: A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SHR-1701 in combination with famitinib in advanced solid tumors across phase 1 and phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Famitinib (Famitinib)
• SHR-1701

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN